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Objectives: The detection of HIV seroconverters increased annually since HIV
antigen/antibody testing kits have been available widely in South Korea. This
study aimed to identify the epidemiological characteristics of HIV seroconverters
and their immune level at HIV diagnosis.
Method: We analyzed the epidemiological and immunological characteristics of
341 HIV seroconverters among 6,008 HIV-diagnosed individuals from 1999 and
2009. The analysis of immune level and epidemiological factors of HIV sero-
converters was conducted by using chi-square test on SAS version 9.1.
Results: The seroconverters among newly-identified HIV cases each year
increased from 0.5% in 1999 to over 5% or in 2009. The sex ratio of seroconverters
was 18:1 (male:female), and 33% were in their 30s, and 28% were in their 20s.
Reasons for HIV testing were involvement in voluntary test due to risky behaviors
(43%), and health check-up (36%). Discovery of HIV infection occurred primarily
in hospitals (84%). Among seroconverters, 55 percent had a CD4 T-cell count of
more than 350/ml.
Conclusion: Korean HIV seroconverters tended to be younger at diagnosis,
diagnosed during a voluntary test, and their CD4þ T-cell counts at HIV diagnosis
were higher than those of non-seroconverters all HIV-infected individuals. This
study of HIV seroconverters will be important foundational in future studies on
HIV incidence, disease progress, and survival rate.1. Introduction
In Korea, around 700e900 cases of human immu-
nodeficiency virus (HIV) infection are reported recentted under the terms of the C
0) which permits unrestrict
roperly cited.
ase Control and Preventionevery year. However, in most cases, it is difficult to
identify the time of infection and nearly 70% of the
cases are diagnosed in a stage where curative treatment
is required [1]. In addition, 99% of HIV infections arereative Commons Attribution Non-Commercial License (http://
ed non-commercial use, distribution, and reproduction in any
. Published by Elsevier Korea LLC. All rights reserved.
246 J.-S. Wang, et alfound to have been transmitted through sexual contact.
By the end of December 2011, the cumulative number
of HIV-infected individuals in Korea reached 8544 and,
of that number, 888 were newly identified in 2011 alone,
which is an almost 15% increase from 1 year earlier.
Although the cumulative number itself is not very large
compared to those of other countries, the annual number
of new HIV infections has continued to rise [2e4].
According to past studies, 40e90% of recent HIV
infections were accompanied by symptoms of acute
retroviral syndrome such as fever, fatigue and sore
throat. However, retrovirus is hard to detect at that stage
with ordinary HIV antibody tests: it is known that only
25% test positive [5]. In the past, the diagnose of early
HIV infection mostly depended on clinical observation
of patients. More recently, however, HIV antigen tests
that allow the diagnosis of HIV infection even in the
pre-seroconversion phase and nucleic acid amplification
tests (NATs) have become widely available, which
made it possible to identify early HIV infection [6]. In
the UK, NATs were administered to acute retroviral
syndrome patients and HIV risk-groups, which resulted
in the diagnosis of early HIV infection [7].
In 2005, diagnostic laboratories in Korea, began
NATs on all blood donations, the fourth-generation
reagent antigen/antibody tests were adopted in HIV
testing laboratories in hospitals, clinics and public health
centers [8]. All these led to an increase in the number of
HIV cases detected at an early stage of infection. In
particular, since there has been a recent increase in the
number of patients who are with a negative or indeter-
minate antibody test but are suspected of HIV infection
among samples submitted for testing. It seems that there
is a need to study the annual number of seroconverters
and the characteristics of and changes in HIV infection
patterns among these patients.
Therefore, this study aimed to find out the scale and
the trend of HIV seroconverters among HIV-diagnosed
individuals in Korea from and analyze their epidemio-
logical characteristics including the reason for HIV
testing and immune status at HIV diagnosis.2. Materials and Methods
2.1. Participants and methods
This study compared and analyzed the epidemiolog-
ical and immunological characteristics of 6008 Koreans
confirmed HIV-positive from 1999 to 2009, of whom
341 were HIV seroconverters. For the purpose of this
study, a seroconverter was defined as a person who
tested positive for a HIV antigen test or NAT and
negative/indeterminate in an antibody western-blottest,
but, after a certain period of time, tested positive
subsequently. For a doubtful seroconvertor sample, we
collected blood again after one weeks to 1 month
depending on their HIV antigen/antibody reactions andHIV testing conducted including western blot and
additional CD4 T-cell counts to assess immune status. If
a sample tested positive depending on western-blot
profile in subsequent testing, the patient was classified
as a seroconverter and registered as a HIV-infected
individual and subjected to an epidemiological study.
2.2. HIV serology tests and CD4 T-cell counts
HIV antigen/antibody tests were conducted using the
particle agglutination assay (SERODIA HIV-1/2;
Fugirebio Inc, Tokyo, Japan) for coagulation response
testing, Micro-ELISA System Antigen (Vironostika
HIV-I Antigen; bioMe´rieux, Lyon, France), and Micro-
ELISA System Antibody (Vironostika HIV Uni-Form II
plus O, bioMe´rieux). Patient samples that tested positive
in HIV antigen/antibody tests were subjected to addi-
tional HIV western blotting (HIV BLOT 2.2 Western
Blot Assay; MP Diagnostics, Geneva, Switzerland) for
confirmatory diagnosis of HIV infection. For CD4 T-cell
counts, flow cytometry was used.
2.3. Statistical analysis
All HIV-infected individuals and seroconverters were
compared on several epidemiological variables: sex,
age, transmission route, screening site, marital status,
reason for HIV testing and CD4 T-cell counts as an
indication of how advanced the disease was. The
subjects were divided into six age groups: <20 years;
20e29 years; 30e39 years; 40e49 years; 50e59 years;
60 years. Marital status was reported as either
"married" or "unmarried", and "married" included
"widowed", "separated", and "divorced". Reasons for
HIV testing were categorized into four groups: health
check-ups, risky behaviors, blood donation, and history
of AIDS-related illness. The health check-up group
included general check-ups, prenatal examinations, and
health check-ups for group home residents. Those who
received HIV testing due to suspicion of HIV infection
were classified as voluntary subjects. The group that
received confirmatory testing due to a history of AIDS-
related illnesses included tuberculosis patients and those
with clinical symptoms associated with AIDS. After
excluding samples with missing values on each variable
from frequency calculations, the distribution proportion
(%) was calculated. Statistical Analysis Software
Version 9.1 was used for frequency analysis and Chi-
square tests. The level of significance for all statistical
analyses was p < 0.05.3. Results
3.1. Distribution of seroconverters among
HIV-infected Koreans by year
From 1999 to 2009, the number of identified HIV
infections was 6008. The annual number of newly
diagnosed individuals has continued to increase: 189 in
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A total of 341 seroconverters were identified during the
11-year period, accounting for 5.6% of all HIV-infected
individuals. Starting with the identification of one
seroconverter in 1999, the number of seroconverters
found in each year has continued to rise, exceeding 30 in
2003 and reaching 69 in 2006. The percentage of sero-
converters among newly-identified HIV cases each year
stayed between 0.5% and 1.2% for 3 years from 1999,
but later increased to 4% in 2002 and to 5% in 2003
and stayed at that level since (Figure 1).3.2. Epidemiological characteristics of
seroconverters in Korea
The epidemiological characteristics of seroconverters
are as indicated in Table 1. Compared to HIV non-
seroconverters, the proportion of men was higher among
seroconverters but there was no statistically significant
difference (p Z 0.085). In a comparison of age distri-
bution, seroconverters showed a higher percentage of
those aged <30 years, while, among non-seroconverters,
the percentage of those in their 40s was relatively
higher, which indicated an age difference between the
two groups (p Z 0.001). As for the route of HIV
infection, both for seroconverters and non-sero-
converters the dominant route of infection was sexual
contact with heterosexual contact being the more likely
route of transmission than homosexual contact. There
was no significant difference between the two groups as
analyzed by transmission route (p Z 0.170), and the
main reason for HIV testing of seroconverters was
voluntary test due to risky behaviors (43%). Their
discovery of HIV infection occurred primarily in
hospitals (84%). And marital status at the time of HIVFigure 1. Annual trend in HIV-infected individuals and HIV
seroconverters from 1999 to 2009. TotalZ the number of HIV-
diagnosed individuals during one year; Seroconverter Z the
number of HIV seroconverters reported during 1 year.diagnosis showed no difference between non-sero-
converters all HIV-infected individuals and sero-
converters (p Z 0.380).
3.3. Level of CD4 T- cell counts of
seroconverters
An analysis of CD4 T-cell count of 231 sero-
converers (Table 1), conducted to estimate the stage of
disease progression, revealed that the average number of
CD4 T-cells was 395  106/L and that 55% had a CD4
T-cell count of >350  106/L. In contrast, only 33% of
non-seroconverters showed a CD4 T-cell count of more
than 350  106/L, which suggests that seroconverters
had a higher CD4 T-cell count at HIV diagnosis
(p < 0.001). Among seroconverters, 13.9% had a CD4
T-cell count <200  106/L.4. Discussion
A comparison of epidemiological characteristics
showed that Korean HIV seroconverters tended to be
younger at diagnosis, detected in hospitals and diag-
nosed during a voluntary test compared to the general
population of HIV-infected individuals. In addition,
their CD4 T-cell counts at HIV diagnosis were higher
than those of all HIV-infected individuals.
Since the first HIV infection in Korea was reported in
1985, the number of new diagnoses each year has
increased to around 100 in 1996 and to >200 in 2000
and thereafter. There now exists a wide spectrum in
diagnosis of HIV infection and an increasing number of
cases whose HIV infection status is hard to determine
[4]. The first case of HIV seroconversion in Korea, re-
ported in 1999, tested positive for antibody in
a screening test but did not meet the criteria for a posi-
tive diagnosis in confirmatory tests using western blot-
ting. One week later, the case could be confirmed
positive for HIV in subsequent testing. Detection of
seroconverters increased as antigen/antibody simulta-
neous testing kits, which are fourth-generation reagents
that make detection possible 3 weeks after infection,
became widely used for screening tests [6].
In our study, the frequency of detection was high in
Korean seroconverters because they often undergo
voluntary testing due to suspicion of HIV infection after
risky behaviors such as homosexual contacts or sex with
unfamiliar partners. They were diagnosed in an early
stage of HIV infection, and understanding their char-
acteristics could prove useful in developing effective
strategies to enhance the early diagnosis of HIV infec-
tion. The findings of the present study emphasize the
importance of raising young people’s awareness of HIV
testing and providing easy access to HIV-related infor-
mation and HIV testing. However, we have some limi-
tations in this study. The seroconverters could be found
lowly, because most of HIV screening sites haven’t








Total 6008 (100.0) 5667 (100.0) 341 (100.0)
Gender 0.085
Female 462 (7.7) 444 (7.8) 18 (5.3)
Male 5546 (92.3) 5223 (92.2) 323 (94.7)
Age group 0.001
<20 129 (2.1) 117 (2.1) 12 (3.5)
20e29 1255 (20.9) 1160 (20.5) 95 (27.9)
30e39 1861 (31.0) 1748 (30.8) 113 (33.1)
40e49 1471 (24.5) 1409 (24.9) 62 (18.3)
50e59 855 (14.2) 819 (14.5) 36 (10.6)
60 437 (7.3) 414 ( 7.3) 23 (6.7)
Screening site <0.001
Public health center 1396 (23.2) 1354 (23.9) 42 (12.3)
Clinic or hospital 4142 (68.9) 3855 (68.0) 287 (84.2)
Blood center 470 (7.8) 458 (8.1) 12 (3.5)
Reason for HIV testinga <0.001
Health check-up 2086 (50.2) 1982 (51.3) 104 (35.5)
Risky behaviors 614 (14.8) 487 (12.6) 127 (43.3)
Confirmation of disease status 1169 (28.1) 1121 (29.0) 48 (16.4)
Blood donation 290 (7.0) 276 (7.1) 14 (4.8)
Transmission routea 0.170
Heterosexual intercourse 2900 (58.2) 2742 (58.5) 158 (54.3)
Homosexual intercourse 2068 (41.5) 1937 (41.3) 131 (45.0)
Other 14 (0.3) 12 (0.3) 2 (0.7)
Marital statusa 0.380
Unmarried 1182 (55.4) 1108 (55.2) 74 (59.2)
Married 951 (44.6) 900 (44.8) 51 (40.8)
Initial CD4þ cell counta <0.001
500 395 (15.3) 337 (14.4) 58 (25.1)
350e499 509 (19.7) 440 (18.7) 69 (29.9)
200e349 762 (29.5) 690 (29.4) 72 (31.2)
<200 913 (35.4) 881 (37.5) 32 (13.9)
aThese percentage figures were calculated after excluding samples with missing values.
248 J.-S. Wang, et alperformed NAT testing except blood centers and there
was a different adaptation time of HIV fourth-generation
reagents at screening sites.
In Korea, the annual number of HIV infections has
increased due to a continuous increase in the number of
HIV testing. Current HIV prevalence in the country is
nearly 0.01% and follows an unchanging pattern [2,3].
With data from HIV testing, we can estimate the overall
HIV prevalence in Korea. However, to understand
accurately the current level of HIV transmission or to
identify transmission risk groups, we need to estimate
HIV incidence. Calculating HIV incidence based on the
number of recent infections including seroconverters
will contribute to the development of more direct and
effective strategies to prevent the spread of HIV.
Therefore, there is a clear need for a study of HIV
incidence. In 1998, the US Centers for Disease Control
developed a plan for a nationwide project called
STARHS (serologic testing algorithm for recent HIV
seroconversion) for the detection of recent HIVseroconversion in 1998 and has been implementing it
both in laboratory settings and on a statistical-
surveillance-work basis [9]. The Centers for Disease
Control has also developed the detuned assay and BED
assay to diagnose recent HIV infections and has per-
formed population-based incidence surveillance using
them since 2005 [10].
The natural history of HIV infection in humans is well
known and the detection of seroconversion in HIV-
affected individuals is of paramount importance for
clinical and preventive research. Because early HIV
patients have a high viral load and thus are likely to
transmit the virus to other individuals, early detection of
seroconversion contributes to the reduction of HIV
transmission. In addition, the infected individuals can
benefit from early treatment and improve their chances of
survival as well. In 1994, the CASCADE cohort was
created with 2000 seroconverters from 15 countries in
Europe including theUK,Australia, andCanada to follow
patients from infection, to the onset of AIDS and to death.
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HIV-associated factors, treatment effects, changes in viral
characteristics over time, immunological and clinical
responses, resistance to drugs, etc. [11e13].
Since a few studies related to the time of HIV
infection, we could not study about the survival rate
after HIV infection, disease progression rate, HIV
dynamics over time, etc. Therefore, detection of sero-
converters is critical to develop treatment strategies for
groups treated with a vaccine or a drug as well as esti-
mating HIV incidence in a region and observing the
effects of HIV prevention education and transmission
pattern changes in HIV risk groups.
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